Kamel Laribi

3PUBLICATIONS
37CO-AUTHORS
Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 07, 2025
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Jennifer A Woyach, Lugui Qiu, Sebastian Grosicki

|Jan 08, 2025
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma.

Nancy L Bartlett, Uwe Hahn, Won-Seog Kim

|Dec 08, 2024
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA.

Mazyar Shadman, Talha Munir, Tadeusz Robak

Pageof 1